Grants for Public housing authorities - Health

This funding opportunity is designed to support research sites that will enroll patients with Type 1 Diabetes at risk of kidney disease, enabling the study of kidney biopsies to advance understanding and treatment of diabetic nephropathy.

This grant provides funding for researchers to develop innovative methods for improving cancer communication and prevention strategies in today's digital landscape, focusing on the impact of online information and health disparities.

This grant provides funding to organizations that engage with justice-involved individuals to conduct research aimed at preventing substance use disorders and overdose, enhancing community support and treatment access.

This funding opportunity provides financial support for research organizations to establish expert panels that will evaluate and curate genomic variants linked to important diseases, enhancing clinical understanding and treatment options.

This funding opportunity provides support for research institutions to conduct early-phase clinical trials focused on cancer prevention interventions across various organ sites.

This funding opportunity provides financial support to organizations working in Malawi to implement comprehensive HIV prevention strategies, focusing on reducing new infections and improving health outcomes for targeted populations.

This NOFO aims to conduct diabetes surveillance across health system and/or health plan membership-based centers to: (1) Estimate incidence and prevalence of diabetes in youth (;lt; 18 years) and young adults (1844 years) in the United States. These estimates are sought by diabetes type, demographic traits, health insurance status, and geographic area to identify disparities in diabetes burden; and (2) Ascertain the prevalence of risk factors for diabetes complications, occurrence of acute and chronic diabetes complications, and use of diabetes medications among youth and young adults with diabetes. This NOFO has two (2) components to achieve the purpose of the program. Component A focuses on surveillance of diabetes among youth (;lt; 18 years) and young adults (1844 years). Component B serves as a Coordinating Center to provide an infrastructure for standardized approaches, analytical methods, and measures to be used for surveillance across sites. It will also develop validation protocols, serve as a data repository, and provide statistical expertise.

This funding opportunity supports innovative research into how inflammasome activation affects individuals with HIV and substance use disorders, aiming to uncover mechanisms and potential therapeutic targets to improve health outcomes.

This funding opportunity supports researchers in analyzing existing data to advance understanding of substance use behaviors and disorders, particularly focusing on innovative approaches and diverse populations.

This funding opportunity supports research projects that develop non-drug interventions to improve sleep health and reduce disparities among underserved populations in the U.S.

This grant provides funding to U.S. higher education institutions to support predoctoral training programs in neuroscience, focusing on developing a diverse group of skilled scientists through comprehensive research training and mentorship.

The "Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research" grant aims to encourage current NCI U01 research projects to incorporate new technologies from the NCI Innovative Molecular Analysis Technologies program, in order to enhance their original research and speed up scientific discoveries in cancer research.

This grant provides funding and support for junior faculty from underrepresented backgrounds in neuroscience to lead independent clinical trials and advance their research careers.

The "Interaction Between Environmental Factors and Lewy Body Dementia" grant aims to fund research that investigates how environmental factors like pollution and metals can cause Lewy Body Dementia, with the goal of finding new, changeable targets for treatment.

The grant titled "BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 Clinical Trials Not Allowed)" is designed to fund exploratory research projects that use innovative methods to understand how brain circuit activity influences mental experiences and behavior, with successful results potentially leading to further research projects.

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit research designed to capacitate, transform, and scale the delivery of HIV testing, prevention, and care services through pharmacists and pharmacies in US and/or global settings. This includes theadvancement of training curricula to enable pharmacy students, pharmacists, pharmacies, and pharmacy systems to deliver the spectrum of needed HIV services with ease, equity, and effectiveness. This NOFO uses the R01 grant mechanism, while RFA-MH-25-186 uses the R21 mechanism. Projects that lack preliminary data or that propose to pilot a novel intervention may be most appropriate for the R21 mechanism. Applications with preliminary data and those proposing large-scale clinical trials or longitudinal analyses should consider using the R01 mechanism.

This funding opportunity supports innovative and high-risk neuroscience research projects that may lack extensive preliminary data, aimed at advancing our understanding of neurological and mental health disorders.

This grant provides funding to support early-career researchers from diverse backgrounds in developing independent careers focused on Alzheimer's disease and related dementias through mentored training and research opportunities.

This funding opportunity supports research using advanced laboratory models to investigate how HIV and various addictive substances interact to affect brain health and neurological disorders.

This funding opportunity supports researchers working on developing and optimizing genome editing therapies for various forms of Alzheimer's Disease-Related Dementias, aiming to advance these treatments towards clinical use.